BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

  May 6, 2026

   · 

  1 min read
• Press Releases

  Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia

  May 6, 2026

   · 

  14 min read
• Press Releases

  Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer

  May 6, 2026

   · 

  11 min read
• Press Releases

  Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

  May 6, 2026

   · 

  20 min read
• Press Releases

  Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors

  May 6, 2026

   · 

  6 min read
• Press Releases

  Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth Phase

  May 6, 2026

   · 

  3 min read
• Press Releases

  Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly

  May 6, 2026

   · 

  4 min read
• Press Releases

  Parker Institute for Cancer Immunotherapy Announces Appointment of Aimee Johnson as Chief Marketing Officer

  May 6, 2026

   · 

  3 min read
• Press Releases

  Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - May 6, 2026

  May 6, 2026

   · 

  1 min read
• Press Releases

  LTZ Therapeutics Raises $38 Million in Support of Advancing Myeloid Engager Immunotherapy Pipeline

  May 6, 2026

   · 

  4 min read